About
Ventripoint Diagnostics Ltd. is a Canadian medical device company focused on developing advanced diagnostic imaging tools for heart disease. The company aims to enhance diagnostic imaging by providing solutions that offer higher performance, lower costs, faster turnaround times, and improved patient comfort compared to traditional methods. Their flagship product, VMS+, is an advanced ultrasound technology that delivers 3D whole-heart imaging with accuracy similar to cardiac MRI. VMS+ measures volumetric parameters and ejection fractions for all four heart chambers, including the right ventricle, which is often challenging to image with standard ultrasound. This system is compatible with existing echocardiography machines, allowing clinicians to conduct efficient and cost-effective heart assessments, leading to timely clinical decisions. Ventripoint's technology is beneficial for monitoring various heart conditions, including congenital heart disease and heart failure. The company markets its products internationally, serving healthcare providers in Canada, Australia, North America, and other global markets.
Technologies
Keywords
Company Information
-
Employees 18
-
Founded 2005
-
Annual Revenue $66000
-
Total Funding $1367000
Location
18 Hook Ave, Toronto, Ontario, Canada, M6P 1T4